.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Medtronic
Harvard Business School
Queensland Health
Farmers Insurance
Citi
Fish and Richardson
Boehringer Ingelheim
AstraZeneca
Colorcon

Generated: June 25, 2017

DrugPatentWatch Database Preview

VASCOR Drug Profile

« Back to Dashboard

Which patents cover Vascor, and when can generic versions of Vascor launch?

Vascor is a drug marketed by Johnson And Johnson and Mallinckrodt and is included in two NDAs.

The generic ingredient in VASCOR is iothalamate meglumine; iothalamate sodium. There is one drug master file entry for this compound. Additional details are available on the iothalamate meglumine; iothalamate sodium profile page.

Summary for Tradename: VASCOR

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list20
Patent Applications: see list2,915
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VASCOR at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Johnson And Johnson
VASCOR
bepridil hydrochloride
TABLET;ORAL019002-001Dec 28, 1990DISCNNoNo► Subscribe► Subscribe
Mallinckrodt
VASCORAY
iothalamate meglumine; iothalamate sodium
INJECTABLE;INJECTION016783-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Johnson And Johnson
VASCOR
bepridil hydrochloride
TABLET;ORAL019002-002Dec 28, 1990DISCNNoNo► Subscribe► Subscribe
Johnson And Johnson
VASCOR
bepridil hydrochloride
TABLET;ORAL019002-003Dec 28, 1990DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VASCOR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Johnson And Johnson
VASCOR
bepridil hydrochloride
TABLET;ORAL019002-001Dec 28, 1990RE30577► Subscribe
Johnson And Johnson
VASCOR
bepridil hydrochloride
TABLET;ORAL019002-003Dec 28, 1990RE30577► Subscribe
Johnson And Johnson
VASCOR
bepridil hydrochloride
TABLET;ORAL019002-002Dec 28, 1990RE30577► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Colorcon
Boehringer Ingelheim
Teva
Fuji
US Department of Justice
Covington
AstraZeneca
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot